115
Participants
Start Date
April 5, 2019
Primary Completion Date
October 25, 2021
Study Completion Date
November 22, 2021
HTX-011
300 mg
Luer lock applicator
Applicator for instillation
Ibuprofen
600 mg
Acetaminophen
1 g
Montefiore Hutchinson Campus, The Bronx
Stony Brook University Hospital, Stony Brook
UPMC Shadyside Hospital, Pittsburgh
UPMC Passavant, Pittsburgh
Penn Presbyterian Medical Center, Philadelphia
Thomas Jefferson University Hospital, Philadelphia
M3 Emerging Medical Research, LLC, Durham
Medical Research of Westchester, Inc, Miami
Professional Health Care of Pinellas, St. Petersburg
University of Louisville Hospital, Louisville
The Ohio State University Wexner Medical Center - University Hospital, Columbus
Cleveland Clinic Fairview, Cleveland
Cleveland Clinic, Cleveland
Midwest Clinical Research Center, LLC, Dayton
Washington University School of Medicine, St Louis
Plano Surgical Hospital, Plano
Baylor University Medical Center, Dallas
Baylor University Medical Center, Dallas
Hermann Drive Surgical Hospital, Houston
Houston Methodist Hospital, Houston
Endeavor Clinical Trials, LLC, San Antonio
JBR Clinical Research, Draper
Horizon Clinical Research, La Mesa
Sharp Grossmont Hospital, La Mesa
Parkview Community Hospital, Riverside
Anaheim Clinical Trials, LLC, Anaheim
University of California, Irvine Medical Center, Orange
Summit Medical Group Oregon-Bend Memorial Clinic, Bend
Yale University School of Medicine, New Haven
Rutgers - New Jersey Medical School, Newark
Lead Sponsor
Heron Therapeutics
INDUSTRY